Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032.

Journal of Translational Medicine
Jill C RubinsteinRuth Halaban

Abstract

Activating mutations in BRAF kinase are common in melanomas. Clinical trials with PLX4032, the mutant-BRAF inhibitor, show promising preliminary results in patients selected for the presence of V600E mutation. However, activating V600K mutation is the other most common mutation, yet patients with this variant are currently excluded from the PLX4032 trials. Here we present evidence that a patient bearing the BRAF V600K mutation responded remarkably to PLX4032, suggesting that clinical trials should include all patients with activating BRAF V600E/K mutations.

References

Sep 23, 2003·The American Journal of Dermatopathology·Pablo UribeSergio González
Jul 18, 2006·Melanoma Research·Jenny N PoynterStephen B Gruber
Aug 11, 2007·The Journal of Molecular Diagnostics : JMD·Cynthia SpittleRobin H Edwards
Apr 17, 2010·Pigment Cell & Melanoma Research·Ruth Halaban
May 18, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christine A Pratilas, David B Solit

❮ Previous
Next ❯

Citations

May 16, 2013·Clinical & Experimental Metastasis·Einar BirkelandPer Eystein Lønning
Feb 20, 2013·Current Treatment Options in Oncology·Douglas B Johnson, Jeffrey A Sosman
Jun 23, 2012·Current Oncology Reports·Janice M Mehnert, Harriet M Kluger
Sep 4, 2012·Immunologic Research·Tullia C BrunoJill E Slansky
May 8, 2013·Drugs·Charlotte LemechHendrik-Tobias Arkenau
Nov 9, 2012·The New England Journal of Medicine·Margaret K CallahanPaul B Chapman
Mar 24, 2011·The Cancer Journal·Mario Sznol
Dec 2, 2011·Cancer Research·Jessie VillanuevaMeenhard Herlyn
Mar 31, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Adina VulturMeenhard Herlyn
Jun 29, 2012·Case Reports in Oncology·Nicola L SchoenewolfUNKNOWN Swiss Group for Clinical Cancer Research (SAKK)
May 5, 2012·Journal of Translational Medicine·Paolo A AsciertoNicola Mozzillo
Nov 1, 2011·PloS One·Hazem El-OstaRazelle Kurzrock
Aug 21, 2012·Cancer Management and Research·Rosalie Fisher, James Larkin
Dec 12, 2012·Pharmacogenomics and Personalized Medicine·Jaykumar ThumarHarriet M Kluger
Mar 8, 2014·Molecular Diagnosis & Therapy·Jonathan C DudleyMing-Tseh Lin
Aug 19, 2014·The Journal of Molecular Diagnostics : JMD·Grace W WeyantKeri J Donaldson
Nov 15, 2011·Cellular and Molecular Life Sciences : CMLS·Almass-Houd Aguissa-Touré, Gang Li
Dec 2, 2015·Expert Review of Molecular Diagnostics·Mona FothWilliam M Gallagher
May 21, 2014·International Journal of Molecular Sciences·Inderjit DaphuFrits Thorsen
Oct 15, 2010·Expert Opinion on Investigational Drugs·Elisabeth LivingstoneDirk Schadendorf
Nov 1, 2015·American Journal of Clinical Dermatology·Hugo Akabane, Ryan J Sullivan
Oct 16, 2015·Hematology/oncology Clinics of North America·Barrett J Rollins
Apr 24, 2013·Clinics in Dermatology·Jaclyn C FlaniganHarriet M Kluger
Feb 27, 2013·Clinics in Dermatology·Ragini R KudchadkarVernon K Sondak
Aug 5, 2015·Journal of Cutaneous Pathology·Nemanja RodićJanis M Taube
Dec 15, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Oliver KleinGeorgina V Long
Jan 16, 2016·Annual Review of Medicine·Warren Fiskus, Nicholas Mitsiades
Apr 27, 2012·Journal of Dermatological Science·Atsuko AshidaRyuhei Okuyama
Apr 10, 2012·Seminars in Oncology·Keiran S M Smalley, Grant A McArthur
Oct 23, 2012·American Journal of Clinical Pathology·Kurt D BernackiMichael H Roh
Dec 1, 2015·Future Oncology·Sebastian ZahnreichHeinz Schmidberger
Jun 18, 2015·Journal of Neuropathology and Experimental Neurology·Aline Paixão BeckerRui M Reis

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Paul B ChapmanBRIM-3 Study Group
The New England Journal of Medicine
Jeffrey A SosmanAntoni Ribas
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Oliver KleinGeorgina V Long
© 2021 Meta ULC. All rights reserved